BioNexus Gene Lab Corp. Cash
BioNexus Gene Lab Corp. (BGLC) had Cash of $2.49 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2024-05-15
- 2024-03-31: Cash $2.49M.
- 2023-12-31: Cash $2.62M.
- 2023-09-30: Cash $4.70M.
- 2023-06-30: Cash $297.08K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2024-03-31 | $2.49M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.62M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $4.70M 10-Q/A · filed 2024-03-26 | |
| 2023-06-30 | $297.08K 10-Q · filed 2023-08-16 | |
| 2023-03-31 | $406.79K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $611.85K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $478.18K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $490.59K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $606.85K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $578.51K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $672.93K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $422.89K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $853.20K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $699.59K 10-K · filed 2022-04-06 | |
| 2020-06-30 | $250.13K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $314.14K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $366.04K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $370.52K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $528.25K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $597.46K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $366.04K 10-K · filed 2021-03-30 | $659.24K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |